Literature DB >> 6298930

Relation between hypercalciuria and vitamin D3-status in patients with urolithiasis.

T Berlin, I Björkhem, L Collste, I Holmberg, H Wijkström.   

Abstract

Patients with urolithiasis were divided into two groups, one (n = 38) with a urinary excretion of calcium exceeding 6.0 mmol/24 h and one (n = 32) with a calcium excretion lower than 6.1 mmol/24 h. The group of patients with a high urinary excretion of calcium had a significantly higher level of 25-hydroxy vitamin D3 (26.2 +/- 1.6 ng/ml) than had the group of patients with a normal urinary excretion of calcium (17.6 +/- 0.9 ng/ml) (p less than 0.001). A highly specific and accurate method, based on isotope dilution--mass spectrometry was used in the assay of 25-hydroxy vitamin D3. There was no over-all correlation between level of 25-hydroxy vitamin D3 and serum level of calcium (r = 0.1). The results are in accordance with the contention that the vitamin D3-status might be of some importance for the development of hypercalciuria in these patients.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6298930     DOI: 10.3109/00365598209179765

Source DB:  PubMed          Journal:  Scand J Urol Nephrol        ISSN: 0036-5599


  9 in total

1.  Combined vitamin D and calcium supplementation in vitamin D inadequate patients with urolithiasis: Impact on hypercalciuria and de novo stone formation.

Authors:  Charles Hesswani; Yasser A Noureldin; Mohamed A Elkoushy; Sero Andonian
Journal:  Can Urol Assoc J       Date:  2015-12-14       Impact factor: 1.862

2.  Association of urinary calcium excretion with serum calcium and vitamin D levels.

Authors:  Anita Rathod; Olivier Bonny; Idris Guessous; Paolo M Suter; David Conen; Paul Erne; Isabelle Binet; Luca Gabutti; Augusto Gallino; Franco Muggli; Daniel Hayoz; Antoinette Péchère-Bertschi; Fred Paccaud; Michel Burnier; Murielle Bochud
Journal:  Clin J Am Soc Nephrol       Date:  2014-12-17       Impact factor: 8.237

3.  Prevalence of Vitamin D Inadequacy in Urolithiasis Patients.

Authors:  Kunal Dholakia; Nivash Selvaraj; Narasimhan Ragavan
Journal:  Cureus       Date:  2021-06-01

4.  Role of 1,25-dihydroxy vitamin D3 and parathyroid hormone in urinary calcium excretion in calcium stone formers.

Authors:  Won Tae Kim; Yong-June Kim; Seok Joong Yun; Kyung-Sub Shin; Young Deuk Choi; Sang Cheol Lee; Wun-Jae Kim
Journal:  Yonsei Med J       Date:  2014-09       Impact factor: 2.759

Review 5.  Association between Circulating Vitamin D Level and Urolithiasis: A Systematic Review and Meta-Analysis.

Authors:  Henglong Hu; Jiaqiao Zhang; Yuchao Lu; Zongbiao Zhang; Baolong Qin; Hongbin Gao; Yufeng Wang; Jianning Zhu; Qing Wang; Yunpeng Zhu; Yang Xun; Shaogang Wang
Journal:  Nutrients       Date:  2017-03-18       Impact factor: 5.717

Review 6.  Vitamin D, Hypercalciuria and Kidney Stones.

Authors:  Emmanuel Letavernier; Michel Daudon
Journal:  Nutrients       Date:  2018-03-17       Impact factor: 5.717

7.  Beta-thalassaemia major: Prevalence, risk factors and clinical consequences of hypercalciuria.

Authors:  Ludovica Aliberti; Irene Gagliardi; Maria Rita Gamberini; Andrea Ziggiotto; Martina Verrienti; Aldo Carnevale; Marta Bondanelli; Maria Chiara Zatelli; Maria Rosaria Ambrosio
Journal:  Br J Haematol       Date:  2022-06-29       Impact factor: 8.615

8.  Effects of high doses of cholecalciferol in normal subjects: a randomized double-blinded, placebo-controlled trial.

Authors:  Birgitte Nygaard; Niels Erik Frandsen; Lisbet Brandi; Knud Rasmussen; Ove Vyff Oestergaard; Lars Oedum; Hans Christian Hoeck; Ditte Hansen
Journal:  PLoS One       Date:  2014-08-28       Impact factor: 3.240

9.  Association between serum vitamin D levels and the risk of kidney stone: evidence from a meta-analysis.

Authors:  Hai Wang; Libo Man; Guizhong Li; Guanglin Huang; Ning Liu
Journal:  Nutr J       Date:  2016-03-31       Impact factor: 3.271

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.